Effect of Lycopene on Peritoneal Fluid Malondialdehyde Level in Endometriosis

Nanang W. Astarto, Tono Djuwantono, Yelliantty
In: Journal Of Medicine & Health · 2015 · vol. 1(1) · doi:10.28932/jmh.v1i1.501 · W2790093464
article OA: diamond CC0
🔓 Open OA copy Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-13 ⓘ

Lycopene supplementation reduced malondialdehyde levels in peritoneal fluid from women with endometriosis compared to fluid without lycopene.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-13 · read from full text ⓘ

The paper studied whether lycopene supplementation alters malondialdehyde (MDA), a marker of oxidative stress, in peritoneal fluid from women with endometriosis. It reports an experimental study using peritoneal fluid samples from five women with endometriosis, comparing MDA levels with versus without lycopene. The key finding was that peritoneal fluid MDA levels were lower with lycopene supplementation. This paper is centrally about endometriosis — it evaluates the effect of lycopene on peritoneal fluid oxidative stress (MDA) in women with endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Oxidative stress is a factor that contribute in pathogenesis of endometriosis. This condition could also implicated in infertility. Lycopene is a carotenoid that has antioxidant activity. Supplementation of lycopene can reduce oxidative stress in peritoneal fluid of women with endometriosis. This study aims to compare the effect of lycopene on malondialdehyde (MDA) levels in peritoneal fluid of women with endometriosis. It is an experimental study on peritoneal fluid from five women with endometriosis. The result show that lycopene supplementation affecting the MDA levels in peritoneal fluid. MDA levels in peritoneal fluid with lycopene is lower than without lycopene. It conclude that lycopene is proved lowering MDA levels in peritoneal fluid of women with endometriosis. Keywords: endometriosis lycopene, malondialdehyde
Full text 2,131 characters · extracted from oa-doi-fallback · click to expand
Effect of Lycopene on Peritoneal Fluid Malondialdehyde Level in Endometriosis DOI: https://doi.org/10.28932/jmh.v1i1.501Abstract Oxidative stress is a factor that contribute in pathogenesis of endometriosis. This condition could also implicated in infertility. Lycopene is a carotenoid that has antioxidant activity. Supplementation of lycopene can reduce oxidative stress in peritoneal fluid of women with endometriosis. This study aims to compare the effect of lycopene on malondialdehyde (MDA) levels in peritoneal fluid of women with endometriosis. It is an experimental study on peritoneal fluid from five women with endometriosis. The result show that lycopene supplementation affecting the MDA levels in peritoneal fluid. MDA levels in peritoneal fluid with lycopene is lower than without lycopene. It conclude that lycopene is proved lowering MDA levels in peritoneal fluid of women with endometriosis. Keywords: endometriosis lycopene, malondialdehydeDownloads Download data is not yet available. Downloads Published 2015-02-27 How to Cite 1. Astarto NW, Djuwantono T, Yelliantty . Effect of Lycopene on Peritoneal Fluid Malondialdehyde Level in Endometriosis. J. Med. Health [Internet]. 2015Feb.27 [cited 2026Jun.13];1(1). Available from: https://journal.maranatha.edu/index.php/jmh/article/view/501 Issue Section Articles License Authors who publish with this journal agree to the following terms: - Authors retain the copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. - Authors are able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisinfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (21)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK